Adeshwar Meditex Limited (BOM:543309)
India · Delayed Price · Currency is INR 17.50
+0.70 (4.17%)
At close: Aug 17, 2026
Adeshwar Meditex Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 12.65 | 20.66 | 20.08 | 20.74 | 7.93 |
Depreciation & Amortization | 4.28 | 4.99 | 6.01 | 5.31 | 3.82 |
Other Amortization | 0.66 | 0.67 | 0.66 | 0.63 | 1.09 |
Loss (Gain) From Sale of Assets | - | 0.06 | - | - | - |
Loss (Gain) From Sale of Investments | - | -1.24 | - | - | - |
Other Operating Activities | 5.35 | 10.35 | 14.89 | 61.7 | 16.24 |
Change in Accounts Receivable | 141.64 | -97.11 | 26.61 | - | -52.19 |
Change in Inventory | 53.23 | 7.04 | -22.06 | 9.79 | 8.07 |
Change in Accounts Payable | -163.89 | 66.88 | -22.6 | -40.42 | 28.81 |
Change in Other Net Operating Assets | -4.24 | 25.69 | 14.8 | -0.09 | -38.12 |
Operating Cash Flow | 49.68 | 38.01 | 38.39 | 57.67 | -24.35 |
Operating Cash Flow Growth | 30.72% | -1.01% | -33.42% | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -0.82 | -1.49 | -4.31 | - | -11.72 |
Sale of Property, Plant & Equipment | - | 2.24 | - | - | - |
Investment in Securities | - | 2.22 | - | 0.02 | -0.16 |
Other Investing Activities | 0.97 | 1.01 | 1.52 | -9.72 | 1.88 |
Investing Cash Flow | 0.96 | 5.09 | -2.23 | -11.59 | -11.56 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | 8.82 | - | - | - |
Total Debt Issued | - | 8.82 | - | - | - |
Short-Term Debt Repaid | -61.69 | -23.14 | -12.83 | -8.09 | -18.66 |
Long-Term Debt Repaid | -2.89 | - | -12.58 | -17.55 | -12.87 |
Total Debt Repaid | -64.58 | -23.14 | -25.4 | -25.64 | -31.52 |
Net Debt Issued (Repaid) | -64.58 | -14.32 | -25.4 | -25.64 | -31.52 |
Issuance of Common Stock | - | - | - | - | 97.5 |
Other Financing Activities | -6.3 | -12.29 | -18.23 | -20.62 | -21.53 |
Financing Cash Flow | -70.88 | -26.61 | -43.63 | -46.25 | 44.45 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | -0 | - | 0 | - |
Net Cash Flow | -20.24 | 16.49 | -7.47 | -0.17 | 8.54 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 48.86 | 36.51 | 34.09 | 57.67 | -36.07 |
Free Cash Flow Growth | 33.81% | 7.11% | -40.89% | - | - |
Free Cash Flow Margin | 8.71% | 4.36% | 4.27% | 7.00% | -5.57% |
Free Cash Flow Per Share | 3.40 | 2.53 | 2.36 | 4.00 | -2.50 |
Levered Free Cash Flow | 42.5 | 16.58 | 14.76 | 30.38 | -36.56 |
Unlevered Free Cash Flow | 46.31 | 24.21 | 25.52 | 42.59 | -24.44 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 5.64 | 11.62 | 17.19 | 19.15 | 19.14 |
Cash Income Tax Paid | 5.2 | 8.41 | 8.1 | 9.36 | 5.61 |
Change in Working Capital | 26.75 | 2.5 | -3.25 | -30.72 | -53.43 |